Latest Developments in Global Ruminant Vaccines Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Ruminant Vaccines Market

  • Pharmaceutical
  • Feb 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In November 2024, KYOTOBIKEN Vaccine announced that its third bovine vaccine product has been approved by the United Arab Emirates (UAE) authorities, with the first batch launched this month. Three bovine vaccines are now registered and available in the UAE: KYOTOBIKEN CATTLEWIN-5K for bovine respiratory diseases, BOVINE EPHEMERAL FEVER VACCINE·K-KB, and KYOTOBIKEN CALFWIN 6 COMBO LIVE VACCINE (also for bovine respiratory diseases).
  • In October 2024, Merck Animal Health announced that the European Medicines Agency had approved BOVILIS ROTAVEC CORONA for subcutaneous injection in pregnant cows and heifers. This vaccine helps stimulate the production of antibodies against E. coli adhesins F5 (K99) and F41, as well as rotavirus and coronavirus. Administered to the dam during pregnancy, BOVILIS ROTAVEC CORONA provides passive protection to the calf against diarrhea caused by rotavirus, coronavirus, and E. coli.
  • In May 2024, Boehringer Ingelheim launched BULTAVO 3, a vaccine designed to protect sheep and cattle against bluetongue virus serotype 3 (BTV-3). BULTAVO 3 is the first vaccine for BTV-3 that prevents both clinical signs and mortality associated with the virus.
  • In August 2023, Zoetis launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic, in various markets across Europe. The test uses a simple flow dipstick method to detect Gram-positive mastitis within eight hours, providing results before the next milking. Since only Gram-positive cases typically respond to antimicrobial treatment, this information allows farmers or veterinarians to administer more targeted therapy, ensuring antimicrobial use is focused solely on cows that require it.
  • In September 2022, Boehringer Ingelheim launched Fencovis, the first vaccine designed to prevent calf diarrhea caused by E. coli F5 and bovine rotavirus, as well as to reduce the severity of diarrhea caused by bovine coronavirus. Along with Fencovis, Boehringer Ingelheim offers a comprehensive approach to cattle farming by providing training and support services aimed at promoting a holistic and efficient farming method.